118 related articles for article (PubMed ID: 9435905)
21. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations.
He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF
J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationship anatomy by network-like similarity graphs and local structure-activity relationship indices.
Wawer M; Peltason L; Weskamp N; Teckentrup A; Bajorath J
J Med Chem; 2008 Oct; 51(19):6075-84. PubMed ID: 18798611
[TBL] [Abstract][Full Text] [Related]
23. Interpreting computational neural network QSAR models: a measure of descriptor importance.
Guha R; Jurs PC
J Chem Inf Model; 2005; 45(3):800-6. PubMed ID: 15921469
[TBL] [Abstract][Full Text] [Related]
24. Generation of QSAR sets with a self-organizing map.
Guha R; Serra JR; Jurs PC
J Mol Graph Model; 2004 Sep; 23(1):1-14. PubMed ID: 15331049
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional QSAR of HPPD inhibitors, PSA inhibitors, and anxiolytic agents: effect of tautomerism on the CoMFA models.
Zou JW; Luo CC; Zhang HX; Liu HC; Jiang YJ; Yu QS
J Mol Graph Model; 2007 Sep; 26(2):494-504. PubMed ID: 17418602
[TBL] [Abstract][Full Text] [Related]
26. Robust QSAR models using Bayesian regularized neural networks.
Burden FR; Winkler DA
J Med Chem; 1999 Aug; 42(16):3183-7. PubMed ID: 10447964
[TBL] [Abstract][Full Text] [Related]
27. Modeling the activity of furin inhibitors using artificial neural network.
Worachartcheewan A; Nantasenamat C; Naenna T; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2009 Apr; 44(4):1664-73. PubMed ID: 18977558
[TBL] [Abstract][Full Text] [Related]
28. Studying the explanatory capacity of artificial neural networks for understanding environmental chemical quantitative structure-activity relationship models.
Yang L; Wang P; Jiang Y; Chen J
J Chem Inf Model; 2005; 45(6):1804-11. PubMed ID: 16309287
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biochemical evaluation, and classical and three-dimensional quantitative structure-activity relationship studies of 7-substituted-1,2,3,4-tetrahydroisoquinolines and their relative affinities toward phenylethanolamine N-methyltransferase and the alpha2-adrenoceptor.
Grunewald GL; Dahanukar VH; Jalluri RK; Criscione KR
J Med Chem; 1999 Jan; 42(1):118-34. PubMed ID: 9888838
[TBL] [Abstract][Full Text] [Related]
30. Three-dimensional quantitative structure-activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study.
Kulkarni SS; Kulkarni VM
J Med Chem; 1999 Feb; 42(3):373-80. PubMed ID: 9986707
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of choline acetyltransferase inhibitors.
Chandrasekaran V; McGaughey GB; Cavallito CJ; Bowen JP
J Mol Graph Model; 2004 Sep; 23(1):69-76. PubMed ID: 15331055
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
[TBL] [Abstract][Full Text] [Related]
33. [Three dimensional quantitative structure-activity relationship of a series of benzocylohepatpyridine farnesyltransferase inhibitors].
Wan SB; Yi X; Guo ZR
Yao Xue Xue Bao; 2002 Apr; 37(4):257-62. PubMed ID: 12579819
[TBL] [Abstract][Full Text] [Related]
34. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
35. 3D-QSAR design of novel antiepileptic sulfamides.
Gavernet L; Dominguez Cabrera MJ; Bruno-Blanch LE; Estiú GL
Bioorg Med Chem; 2007 Feb; 15(3):1556-67. PubMed ID: 17158052
[TBL] [Abstract][Full Text] [Related]
36. QSAR study on the antinociceptive activity of some morphinans.
Ramírez-Galicia G; Garduño-Juárez R; Hemmateenejad B; Deeb O; Deciga-Campos M; Moctezuma-Eugenio JC
Chem Biol Drug Des; 2007 Jul; 70(1):53-64. PubMed ID: 17630995
[TBL] [Abstract][Full Text] [Related]
37. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
38. 3D-QSAR analysis of conformationally constrained diacylglycerol (DAG) analogues as potent protein kinase C (PK-C) ligands.
Kim SY; Lee J
Bioorg Med Chem; 2004 May; 12(10):2639-44. PubMed ID: 15110845
[TBL] [Abstract][Full Text] [Related]
39. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
Pandey G; Saxena AK
J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
[TBL] [Abstract][Full Text] [Related]
40. Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.
Afzelius L; Zamora I; Masimirembwa CM; Karlén A; Andersson TB; Mecucci S; Baroni M; Cruciani G
J Med Chem; 2004 Feb; 47(4):907-14. PubMed ID: 14761192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
